Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis (JIA) patients

被引：0
|
作者：
South-Wood, Taunton [1 ]
Cummins, Carole [1 ]
Cotter, Catherine [1 ]
Rahman, Joy [1 ]
机构：
[1] Univ Birmingham, Birmingham, W Midlands, England
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S943 / S944
页数：2
相关论文
共 50 条
  • [1] Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients
    Southwood, Taunton R.
    Foster, Helen E.
    Davidson, Joyce E.
    Hyrich, Kimme L.
    Cotter, Catherine B.
    Wedderburn, Lucy R.
    Hull, Richard G.
    Venning, Helen E.
    Rahman, Joy K.
    Cummins, Carole L.
    RHEUMATOLOGY, 2011, 50 (01) : 189 - 195
  • [2] Discontinuation of etanercept after successful treatment in patients with juvenile idiopathic arthritis
    Remesal, A.
    Casado, R.
    Merino, R.
    De Inocencio, J.
    Garcia-Consuegra, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 420 - 420
  • [3] Safety of etanercept for treatment of juvenile idiopathic arthritis (JIA) - Data of the German etanercept JIA registry
    Hornett, G
    Kuester, R
    Girschick, H
    Foeldvari, I
    Moebius, D
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 72 - 72
  • [4] Discontinuation of Etanercept After Successful Treatment in Patients with Juvenile Idiopathic Arthritis
    Remesal, Agustin
    De Inocencio, Jaime
    Merino, Rosa
    Garcia-Consuegra, Julia
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (09) : 1970 - 1971
  • [5] Etanercept discontinuation in a cohort of juvenile idiopathic arthritis patients: etanercept inefficacy but not intolerance is associated with oral corticosteroid use
    TR Southwood
    CL Cummins
    C Cotter
    J Rahman
    Pediatric Rheumatology, 6 (Suppl 1)
  • [6] Safety and Efficacy of Etanercept in 2000 Patients with Juvenile Idiopathic Arthritis (JIA) in the JIA Biologics Register
    Horneff, Gerd
    Brunner, Juergen
    Haas, Johannes Peter
    Ganser, Gerd
    Foeldvari, Ivan
    Hospach, Toni
    Minden, Kirsten
    Huppertz, Hans-Iko
    Kuester, Rolf M.
    Trauzeddel, Ralf
    Thon, Angelika
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [7] Treatment of patients with juvenile idiopathic arthritis (JIA) in a population-based cohort
    Zamora-Legoff, Jorge A.
    Krause, Megan L.
    Crowson, Cynthia S.
    Muskardin, Theresa Wampler
    Mason, Thomas
    Matteson, Eric L.
    CLINICAL RHEUMATOLOGY, 2016, 35 (06) : 1493 - 1499
  • [8] Treatment of patients with juvenile idiopathic arthritis (JIA) in a population-based cohort
    Jorge A. Zamora-Legoff
    Megan L. Krause
    Cynthia S. Crowson
    Theresa Wampler Muskardin
    Thomas Mason
    Eric L. Matteson
    Clinical Rheumatology, 2016, 35 : 1493 - 1499
  • [9] Discontinuation of etanercept after clinical remission in patients with juvenile idiopathic arthritis
    Jean-David Cohen
    Dominique Fournet
    Catherine Ludwig
    Marie-Cécile Bozonnat
    Michel Rodiere
    Christian Jorgensen
    Pediatric Rheumatology, 10 (Suppl 1)
  • [10] Long-term safety of Etanercept in patients with juvenile idiopathic arthritis (JIA)
    Minden, K.
    Klotsche, J.
    Niewerth, M.
    Horneff, G.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 13 - 13
12345